Abstract:Background: In the past two decades, a large-scale survey of hemoglobinopathies and thalassemia was carried out in mainland China, involving nearly one million people in 28 provinces. The incidences of hemoglobin (Hb) variants, α-thalassemia and β-thalassemia were 0.33%, 2.64% and 0.66%, respectively. The chemical structural analysis identified 67 Hb variants. Among them, 20 are new variants. The analysis of the α-globin gene organization in 111 HbH patients showed 76 cases (68.5%) were of the deletion type, 8 had Hb Constant Spring and the other cases were of non-deletion type. The results of the molecular characterization of more than 200 β-thalassemia alleles showed that the most common types of β-thalassemia mutations in China are CD 41/42 (−4 bp), IVS-II-nt.654 C→T, CD 17 A→T, CD 71/72 (+A) and −28 A→G. Methods: To explore the simple method for molecular diagnosis of β-thalassemia, multiplex allele-specific amplification (MAS-PCR) was used that could simultaneously detect the above five common types of β-thalassemia mutations. Results: Based on the molecular analysis of β-thalassemia intermedia, β-thalassemia homozygotes or compound heterozygotes combined with α-thalassemia, as well as the conjunctive abnormalities of β-thalassemia heterozygote with triplicated haplotype of α-globin genes, were the most common cause of thalassemia intermedia in China. We also used the RT-PCR quantitation method to show that the most common β-thalassemia allele, IVS-II-nt.654 C→T, still produced a small amount (about 15%) of normally spliced β-globin mRNA, therefore, causing β+-thalassemia. In clinical trials of hydroxyurea (HU) treatment for β-thalassemia patients, we found that HU may enhance the expression of the β-globin gene in some patients, leading to an alleviation of clinical symptoms. In the studies of the reversal of aberrant splicing of IVS-II-nt.654 C→T allele by the antisense approach, we constructed a mammalian expression vector that can produce an antisense RNA targeting against the aberrant splice sites of IVS-II-nt.654 C→T pre-mRNA. Conclusions: The results indicated that the antisense RNA produced from the vector could efficiently suppress the aberrant splicing pattern and restore the correct splicing pathway in vitro and in vivo, leading to the improvement of globin chain biosynthesis in thalassemia cells.

A novel Globin Gene Cluster Duplication, <SUP>380</SUP> Heterozygous <SUP>0</SUP>-Thal Variant, Leading to a Blood Transfusion-Dependent Phenotype

A Novel 165 Kb Duplication Involving the α-Globin Gene Cluster Is Identified by Low-Pass Whole Genome Sequencing in a Chinese Thalassemia Intermedia Patient

Characterization of a novel HBB:c.194dup variant of the β-globin gene combined with six alpha genes

Case report: Identification of a novel triplication of alpha-globin gene by the third-generation sequencing: pedigree analysis and genetic diagnosis

Characterization of a novel 8.2 kb deletion causing beta-thalassemia

A novel double heterozygote of HBB c.[219T ＞A;220G ＞T]: gene diagnosis and pedigree analysis

Genetic and phenotypic analysis of a rare asymptomatic case of a homozygous Chinese Gγ+(Aγδβ)0-thalassemia deletion in a Chinese family.

Two Novel Copy Number Variations Involving the Α-Globin Gene Cluster on Chromosome 16 Cause Thalassemia in Two Chinese Families

Severe Transfusion-Dependent Thalassemia in Compound Heterozygote Palestinian Siblings with Two α-Globin Gene Defects, Hb Taybe D HBA1: C.119_121delCCA Mutation and HBA2: C.*94A > G Mutation

Molecular Genetic Characteristics of a Family Which Coinheritance of Rare-88 C>G ( HBB:c.-138 C>G) Β-Thalassemia Mutation with Α-Thalassemia and Review of the Literature

Mutational analysis of thalassemia in transfusion-dependent beta-thalassemia patients from central India

Five novel globin gene mutations identified in five Chinese families by next-generation sequencing

Two Novel Β-Thalassemia Gene Mutations Were Detected in Chinese Patients: CD13/14(-C) and Beta Nt1582(a>g), PolyA(AATAAA>GATAAA)

The carriage rates of <SUP>anti3.7</SUP>, <SUP>anti4.2</SUP>, and HK in the population of Guangxi, China measured using a rapid detection qPCR system to determine CNV in the -globin gene cluster

Identification of a Novel Variant c.163delG in HBB Gene Resulting in a Beta Null Phenotype in a Proband with Thalassemia Intermedia

The Studies of Hemoglobinopathies and Thalassemia in China--the Experiences in Shanghai Institute of Medical Genetics.

Two Novel Deletion Mutations in Β-Globin Gene Cause Β-Thalassemia Trait in Two Chinese Families

Genetic research and clinical analysis of deletional Chinese Gγ+(Aγδβ)0 -thalassemia and Southeast Asian HPFH in South China

Identification of a novel 10.3 kb deletion causing α 0 -thalassemia by the third-generation sequencing: pedigree analysis and genetic diagnosis

A Novel Fusion Gene and a Common Α(0)-Thalassemia Deletion Cause Hemoglobin H Disease in a Chinese Family.

Alpha globin gene alterations modifying the phenotype of homozygous beta thalassaemia